Main Session
Sep
30
QP 12 - CNS 4: Quick Pitch: Trials, Toxicity, and Translational Updates in CNS
1070 - Induction-Concurrent Chemoradiotherapy with or without Camrelizumab for Postoperative Residual High-Grade Gliomas: An Open, Randomized, Phase II Clinical Study
Presenter(s)
Guiying Huang, MB - Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province